Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Centrosome | 7 | 2021 | 30 | 2.350 |
Why?
|
| E2F Transcription Factors | 6 | 2019 | 11 | 1.680 |
Why?
|
| E2F3 Transcription Factor | 8 | 2021 | 12 | 1.430 |
Why?
|
| Breast Neoplasms | 9 | 2025 | 1723 | 1.430 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2013 | 8 | 1.050 |
Why?
|
| Mitosis | 5 | 2021 | 114 | 0.810 |
Why?
|
| Cell Movement | 2 | 2021 | 655 | 0.660 |
Why?
|
| Protein Kinases | 1 | 2021 | 100 | 0.660 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 74 | 0.540 |
Why?
|
| Chromatin | 2 | 2018 | 186 | 0.500 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 455 | 0.490 |
Why?
|
| Cell Line, Tumor | 8 | 2024 | 2676 | 0.470 |
Why?
|
| Gene Silencing | 2 | 2015 | 154 | 0.470 |
Why?
|
| DNA | 1 | 2018 | 592 | 0.440 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 333 | 0.420 |
Why?
|
| Cell Cycle Proteins | 5 | 2019 | 241 | 0.400 |
Why?
|
| Cell Cycle | 6 | 2014 | 346 | 0.390 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2009 | 220 | 0.370 |
Why?
|
| Chromosomal Instability | 3 | 2021 | 20 | 0.360 |
Why?
|
| Retinoblastoma Protein | 6 | 2007 | 29 | 0.360 |
Why?
|
| Transcription Factors | 5 | 2014 | 735 | 0.360 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1019 | 0.340 |
Why?
|
| Mice | 14 | 2021 | 6644 | 0.340 |
Why?
|
| Genes, ras | 1 | 2010 | 24 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2024 | 968 | 0.320 |
Why?
|
| Mammary Glands, Animal | 1 | 2010 | 23 | 0.320 |
Why?
|
| Cyclin D1 | 1 | 2010 | 44 | 0.320 |
Why?
|
| Animals | 17 | 2021 | 16992 | 0.320 |
Why?
|
| Female | 15 | 2025 | 24698 | 0.320 |
Why?
|
| Centrioles | 1 | 2009 | 2 | 0.320 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2009 | 32 | 0.310 |
Why?
|
| Signal Transduction | 6 | 2024 | 2157 | 0.290 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1455 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 300 | 0.250 |
Why?
|
| Humans | 15 | 2025 | 43102 | 0.250 |
Why?
|
| Fibroblasts | 6 | 2014 | 281 | 0.240 |
Why?
|
| Tissue Array Analysis | 1 | 2025 | 80 | 0.230 |
Why?
|
| Aneuploidy | 2 | 2021 | 24 | 0.220 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 561 | 0.220 |
Why?
|
| DNA Replication | 2 | 2014 | 148 | 0.210 |
Why?
|
| E2F2 Transcription Factor | 5 | 2007 | 7 | 0.200 |
Why?
|
| Epithelial Cells | 2 | 2021 | 434 | 0.200 |
Why?
|
| E2F1 Transcription Factor | 5 | 2007 | 22 | 0.200 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1070 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 2 | 2000 | 196 | 0.180 |
Why?
|
| Mice, SCID | 1 | 2021 | 158 | 0.170 |
Why?
|
| Phosphorylation | 5 | 2020 | 986 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2020 | 127 | 0.160 |
Why?
|
| ras Proteins | 1 | 2000 | 54 | 0.160 |
Why?
|
| Survival Analysis | 1 | 2021 | 368 | 0.160 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1999 | 2 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 290 | 0.160 |
Why?
|
| Thyroid Neoplasms | 1 | 2000 | 50 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 110 | 0.160 |
Why?
|
| Chromosome Deletion | 1 | 1999 | 53 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 347 | 0.150 |
Why?
|
| Retina | 1 | 2002 | 289 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 137 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 139 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 189 | 0.140 |
Why?
|
| Apoptosis | 5 | 2014 | 1568 | 0.140 |
Why?
|
| Sonication | 1 | 2018 | 14 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2013 | 883 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2024 | 719 | 0.140 |
Why?
|
| Mice, Knockout | 7 | 2014 | 1035 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2013 | 411 | 0.130 |
Why?
|
| Phenotype | 2 | 2015 | 780 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2010 | 165 | 0.130 |
Why?
|
| S Phase | 3 | 2013 | 36 | 0.130 |
Why?
|
| Transfection | 2 | 2015 | 532 | 0.120 |
Why?
|
| Genotype | 2 | 2015 | 800 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2015 | 84 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 495 | 0.110 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 21 | 0.110 |
Why?
|
| Immunohistochemistry | 4 | 2025 | 934 | 0.110 |
Why?
|
| RNA Interference | 1 | 2015 | 247 | 0.110 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 37 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2010 | 1621 | 0.110 |
Why?
|
| Mice, Nude | 1 | 2015 | 408 | 0.110 |
Why?
|
| Lentivirus | 1 | 2013 | 24 | 0.100 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 118 | 0.100 |
Why?
|
| Florida | 2 | 2025 | 478 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 196 | 0.100 |
Why?
|
| Cell Division | 3 | 2003 | 311 | 0.100 |
Why?
|
| Autophagy | 1 | 2014 | 140 | 0.100 |
Why?
|
| Time Factors | 2 | 2015 | 1857 | 0.090 |
Why?
|
| Embryo, Mammalian | 2 | 2003 | 157 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2010 | 665 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2014 | 358 | 0.090 |
Why?
|
| Prognosis | 1 | 2014 | 861 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 307 | 0.080 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2010 | 2 | 0.080 |
Why?
|
| Puerto Rico | 2 | 2025 | 1413 | 0.080 |
Why?
|
| Cell Line | 3 | 2009 | 1410 | 0.080 |
Why?
|
| Gene Knockout Techniques | 1 | 2009 | 53 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2006 | 56 | 0.070 |
Why?
|
| Cell Nucleus | 3 | 2014 | 383 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 458 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 436 | 0.070 |
Why?
|
| Nucleotides | 1 | 2024 | 37 | 0.060 |
Why?
|
| Metabolomics | 1 | 2024 | 95 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 183 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 95 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2024 | 187 | 0.050 |
Why?
|
| Cyclin E | 1 | 2003 | 14 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 26 | 0.050 |
Why?
|
| Mutation | 3 | 2007 | 1177 | 0.050 |
Why?
|
| DNA Repair | 2 | 2014 | 198 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2003 | 104 | 0.050 |
Why?
|
| Fetal Death | 1 | 2002 | 18 | 0.050 |
Why?
|
| Registries | 1 | 2024 | 437 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2003 | 152 | 0.050 |
Why?
|
| Aged | 2 | 2025 | 8214 | 0.050 |
Why?
|
| Placenta | 1 | 2003 | 117 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 945 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2000 | 14 | 0.040 |
Why?
|
| Protein Phosphatase 2 | 1 | 2000 | 26 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2000 | 27 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 31 | 0.040 |
Why?
|
| Doxycycline | 1 | 2000 | 32 | 0.040 |
Why?
|
| Oncogene Proteins v-mos | 1 | 1999 | 1 | 0.040 |
Why?
|
| Leukemia Virus, Murine | 1 | 1999 | 3 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 49 | 0.040 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 1999 | 7 | 0.040 |
Why?
|
| Cell Transformation, Viral | 1 | 1999 | 24 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1999 | 64 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2000 | 50 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2000 | 65 | 0.040 |
Why?
|
| Flavonoids | 1 | 2000 | 100 | 0.040 |
Why?
|
| Middle Aged | 2 | 2025 | 12222 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 508 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 1999 | 462 | 0.040 |
Why?
|
| Adult | 2 | 2025 | 13872 | 0.040 |
Why?
|
| DNA Damage | 2 | 2014 | 356 | 0.030 |
Why?
|
| Pregnancy | 1 | 2002 | 1772 | 0.030 |
Why?
|
| Cyclin G2 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Gene Targeting | 2 | 2007 | 39 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2014 | 47 | 0.030 |
Why?
|
| Homozygote | 1 | 2014 | 77 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 97 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 1869 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2004 | 168 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 592 | 0.020 |
Why?
|
| Rats | 1 | 2000 | 3735 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1542 | 0.020 |
Why?
|
| G1 Phase | 1 | 2006 | 31 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 2004 | 52 | 0.010 |
Why?
|
| Retroviridae | 1 | 2004 | 25 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2004 | 62 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 34 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 150 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 148 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 244 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2003 | 4 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 712 | 0.010 |
Why?
|
| Trophoblasts | 1 | 2003 | 33 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 652 | 0.010 |
Why?
|
| Fetus | 1 | 2003 | 101 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 228 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 134 | 0.010 |
Why?
|
| Cyclins | 1 | 2001 | 34 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 526 | 0.010 |
Why?
|
| Integrases | 1 | 2001 | 28 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 667 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 1082 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2001 | 190 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 456 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1271 | 0.010 |
Why?
|
| Male | 2 | 2006 | 23409 | 0.010 |
Why?
|